Safety and Efficacy of a Bausch & Lomb Multipurpose Solution When Compared to Ciba Vision Aquify Multipurpose Solution
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00636363 |
|
Recruitment Status :
Completed
First Posted : March 14, 2008
Results First Posted : April 8, 2011
Last Update Posted : March 24, 2015
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Contact Lens Solutions | Device: Bausch & Lomb Multipurpose Solution - Rub Care Device: Bausch & Lomb Multipurpose Solution - No Rub Care Device: Ciba Vision Aquify Multipurpose Solution | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 541 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Investigator) |
| Primary Purpose: | Supportive Care |
| Study Start Date : | March 2008 |
| Actual Primary Completion Date : | August 2008 |
| Actual Study Completion Date : | August 2008 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Multipurpose Solution - Rub Care
Bausch & Lomb Multipurpose Solution for use with contact lens care
|
Device: Bausch & Lomb Multipurpose Solution - Rub Care
Daily care for contact lenses - rub care regimen |
|
Experimental: Multipurpose Solution - No Rub Care
Bausch & Lomb Multipurpose Solution for use with contact lens care
|
Device: Bausch & Lomb Multipurpose Solution - No Rub Care
Daily care for contact lenses - no rub care regimen |
|
Active Comparator: Ciba Vision Aquify Multipurpose Solution
Ciba Vision Aquify Multipurpose Solution for use with contact lens care
|
Device: Ciba Vision Aquify Multipurpose Solution
daily care for contact lenses |
- Slit-lamp Findings > Grade 2 [ Time Frame: Over 4 visits for 3 month period ]eyes with any slit lamp findings greater than Grade 2 at any visit. Slit lamp findings for each eye will be graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). Epithelial edema, epithelial microcysts, corneal staining, limbal injection, bulbar injection, superior tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates will be assessed.
- Subjective Responses to Comfort Related Symptoms/Complaints [ Time Frame: Over 4 visits for the 3 month period ]Subject symptoms/complaints will be assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.
- Contact Lens Deposits [ Time Frame: At each visit for 3 months ]Lens deposits assessed at each follow-up visit. Degree of deposits assessed as none, light, medium, or heavy.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- subject is a habitual wearer of a silicone hydrogel or group IV contact lens
- VA correctable to 0.3 LogMar or better (driving vision)
- Clear central cornea
- Subject uses a lens care system on a regular basis
Exclusion Criteria:
- Systemic disease affecting ocular health
- Using systemic or topical medications
- wear monovision, multifocal or toric contact lenses
- Any grade 2 or greater slit lamp findings
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00636363
| United States, New York | |
| Place Eye Care | |
| LeRoy, New York, United States, 14482 | |
| Study Director: | Mohinder Merchea, OD, PhD | Bausch & Lomb Incorporated |
| Responsible Party: | Bausch & Lomb Incorporated |
| ClinicalTrials.gov Identifier: | NCT00636363 |
| Other Study ID Numbers: |
554 |
| First Posted: | March 14, 2008 Key Record Dates |
| Results First Posted: | April 8, 2011 |
| Last Update Posted: | March 24, 2015 |
| Last Verified: | March 2015 |
|
Pharmaceutical Solutions |

